Arriving at FDA:
Arriving at FDA’s White Oak campus may be overwhelming the first time. Please leave lots of extra time to make the trip. Whether you are planning to drive or take public transportation, please factor in extra time for traffic, parking, shuttle buses and security check-in. If you’re flying into the Washington, D.C., metropolitan area, please see the end of this document for additional travel tips.
The meeting will take place at the FDA White Oak Campus at 10903 New Hampshire Ave., Building 31 Conference Center, Section A of the Great Room (Rm. 1503), Silver Spring, MD 20993.
All visitors should park in the SE Quadrant Surface Lot. Proceed to the first stop sign and turn right on Southwest Loop Road. Follow Southwest Loop Road all the way around, passing the SW Garage on your left. Continue driving, enter surface parking lot on your left. Once parked, walk or take the Campus Circulator Shuttle which will service the SE Quadrant Surface Lot and take visitors to Building 1. See map attached.
Silver Spring Metro Station, on the Red Line, is the closest metro stop. The Silver Spring Metro Station is approximately 4 miles, a 20 minute cab ride, from the White Oak Campus. Ride-On Bus route 22 operates between the Silver Spring Metro Station and White Oak Campus. Additionally, C8 Metro Bus operates between College Park and White Flint and makes a stop at the FDA White Oak Campus. For more information and bus schedules, visit: http://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241743.htm.
All participants must enter though Building 1 where they will go through the routine security check procedures for building entry. A visitor badge and escort will not be required to attend a public meeting in the Great Room. You will may have to go through a screening process similar to airport security. Please bring a photo ID for the security check-in.
Please feel free to bring coffee, drinks and snacks with you to the meeting. There is a refreshment stand near the meeting space with light refreshments and coffee for purchase. However, there is no other on-campus dining for visitors. Name Tags: There will be name tags outside the room, where you can list your full name, first name or initials (in case privacy issues are of concern). The panelists will use their full names and will be shown in the camera. Those in the audience will not be shown on camera or have their full names used.
Unite Narcolepsy has spoken with FDA about patients’ symptoms possibly happening during the meeting (like cataplexy or sleepiness). People with narcolepsy and loved ones will be seated together so you will be surrounded by peers who understand. There will also be a separate room nearby available to rest or nap. You are invited to take a break at any time, stand in the back of the room, visit the refreshments station or rest in the separate resting room.
Additionally, we’ve spoken with FDA about cataplexy possibly happening during patient speaking opportunities. We’ve suggested that folks may remain seated and that someone else can hold the microphone if cataplexy is a concern. If there are any other specific accommodation requests, please contact Pujita Vaidya at the FDA: Pujita.Vaidya@fda.hhs.gov.
Speaking Opportunities/Giving Input:
Ten people will be chosen by FDA to participate as panelists during the in-person FDA Meeting on Sept. 24. If you’d like to be considered for this speaking role, you must indicate so while registering. To be considered for a panelist position, you must answer the FDA’s Questions and return them to PatientFocused@fda.hhs.gov by September 13, 2013. Panelists will be notified of their selection around Sept. 17. Given the overwhelming interest in the panelist spots, you may not be selected, but there are other speaking opportunities for patient advocates at the meeting. The FDA will ask specific questions to the audience in a facilitated discussion. There will also be “open-mic” time allowing individuals an optional 3 minutes of remarks.
During the meeting FDA will also ask several polling questions. Patients and advocates attending in person will have “clicker” devices to register their answers. People watching by webcast will also be able to register their response to polling questions.
There is no requirement to speak at the meeting. If you’d like to attend and not speak, this is perfectly acceptable. Thank you!
DC Area Airports: